The Food and Drug Administration has played a large role in the COVID-19 response and is also amid widespread digital transformation. Chief Technology Officer Vid Desai joined the agency two years ago and brings private-sector experience from the health technology industry. Desai observes the similarities of FDA’s tech focus with those in his private industry experiences, discusses how he’s driving change from a business perspective to meet the mission, and shares examples of how innovation in data can unlock efficiencies and opportunities for medical devices and the public.
-
Vid Desai Chief Technology Officer FDA
Related Content
-
IT Officials Are Finding Efficiencies Across Cloud, Data Networks
Federal government agencies are utilizing data to integrate capabilities into environments and better deliver on mission.
4m read -
Agentic AI Raises New Security Challenges for Federal Agencies
Agencies are emphasizing risk management and real-time monitoring to keep ahead of potential challenges caused by legitimate and adversary AI agents.
3m read -
The Cybersecurity Nightmares Threatening Modern Organizations
Cybersecurity leaders examine the hidden threats facing organizations, from shadow AI and legacy systems to alert fatigue, analyst burnout and emerging AI risks.
17m watch -
AI Adoption Pushes Agencies to Rethink Infrastructure, Costs
Federal technology leaders are prioritizing flexible infrastructure, cost management and human oversight as AI takes on more complex tasks.
3m read
